Stevens-Johnson syndrome other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Stevens-Johnson syndrome}} | {{Stevens-Johnson syndrome}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{AHS}} | ||
==Overview== | ==Overview== | ||
Some people have a genetic predisposition which increases their risk of developing SJS in response to certain trigger medications. Genetic testing can be done to identify genetic predisposition in those with a family history or recurrent episodes of SJS | |||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Some people have a genetic predisposition which increases their risk of developing SJS in response to certain trigger medications. Genetic testing can be done to identify genetic predisposition in those with a family history or recurrent episodes of SJS<ref name="pmid24871931.">{{cite journal| author=Li X, Yu K, Mei S, Huo J, Wang J, Zhu Y et al.| title=HLA-B*1502 increases the risk of phenytoin or lamotrigine induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: evidence from a meta-analysis of nine case-control studies. | journal=Drug Res (Stuttg) | year= 2015 | volume= 65 | issue= 2 | pages= 107-11 | pmid=24871931. | doi=10.1055/s-0034-1375684 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24871931 }}</ref><ref name="pmid3189112">{{cite journal| author=| title=[Abstracts of the 23d meeting of the Clinical Immunology Working Group of the East German Society of Clinical and Experimental Immunology organized jointly with the 16th meeting of the Working Group on Infection Immunology of the East German Society of Microbiology and Epidemiology. Berlin, 14 May 1987]. | journal=Allerg Immunol (Leipz) | year= 1988 | volume= 34 | issue= 2 | pages= 119-33 | pmid=3189112 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3189112 }}</ref><ref name="pmid21428769">{{cite journal| author=McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavičiūtė D, Carrington M et al.| title=HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. | journal=N Engl J Med | year= 2011 | volume= 364 | issue= 12 | pages= 1134-43 | pmid=21428769 | doi=10.1056/NEJMoa1013297 | pmc=3113609 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21428769 }}</ref> | |||
* | |||
==References== | ==References== | ||
Latest revision as of 20:45, 29 August 2018
|
Stevens-Johnson syndrome Microchapters |
|
Differentiating Stevens-Johnson Syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Stevens-Johnson syndrome other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Stevens-Johnson syndrome other diagnostic studies |
|
Stevens-Johnson syndrome other diagnostic studies in the news |
|
Risk calculators and risk factors for Stevens-Johnson syndrome other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2]
Overview
Some people have a genetic predisposition which increases their risk of developing SJS in response to certain trigger medications. Genetic testing can be done to identify genetic predisposition in those with a family history or recurrent episodes of SJS
Other Diagnostic Studies
Some people have a genetic predisposition which increases their risk of developing SJS in response to certain trigger medications. Genetic testing can be done to identify genetic predisposition in those with a family history or recurrent episodes of SJS[1][2][3]
References
- ↑ Li X, Yu K, Mei S, Huo J, Wang J, Zhu Y; et al. (2015). "HLA-B*1502 increases the risk of phenytoin or lamotrigine induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: evidence from a meta-analysis of nine case-control studies". Drug Res (Stuttg). 65 (2): 107–11. doi:10.1055/s-0034-1375684. PMID 24871931. Check
|pmid=value (help). - ↑ "[Abstracts of the 23d meeting of the Clinical Immunology Working Group of the East German Society of Clinical and Experimental Immunology organized jointly with the 16th meeting of the Working Group on Infection Immunology of the East German Society of Microbiology and Epidemiology. Berlin, 14 May 1987]". Allerg Immunol (Leipz). 34 (2): 119–33. 1988. PMID 3189112 Check
|pmid=value (help). - ↑ McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavičiūtė D, Carrington M; et al. (2011). "HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans". N Engl J Med. 364 (12): 1134–43. doi:10.1056/NEJMoa1013297. PMC 3113609. PMID 21428769.